You are here

A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

Last updated on June 4, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Non-alcoholic Steatohepatitis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-70 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Males, or females of nonchildbearing potential

- 18 to 70 years of age

- Type 2 Diabetes Mellitus

- Liver fat >/=8% by MRI-PDFF

- On stable dose of metformin monotherapy for at least 2 months (at a dose of at least
500 mg daily)

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- History of other liver disease

- Unable to have an MRI performed

- Significant weight loss in the previous month and/or participant in current weight
loss program

- History of diabetic complications with end-organ damage

NCT03969719
Pfizer
Not yet recruiting
A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now